RAPT Therapeutics Inc (RAPT)
4.03
-0.11
(-2.66%)
USD |
NASDAQ |
May 17, 16:00
4.03
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Accounts Payable (Quarterly): 6.771M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.771M |
December 31, 2023 | 5.176M |
September 30, 2023 | 5.297M |
June 30, 2023 | 2.69M |
March 31, 2023 | 8.941M |
December 31, 2022 | 3.365M |
September 30, 2022 | 4.043M |
June 30, 2022 | 4.097M |
March 31, 2022 | 1.936M |
December 31, 2021 | 1.999M |
September 30, 2021 | 4.017M |
Date | Value |
---|---|
June 30, 2021 | 2.714M |
March 31, 2021 | 3.131M |
December 31, 2020 | 2.383M |
September 30, 2020 | 4.405M |
June 30, 2020 | 2.381M |
March 31, 2020 | 3.409M |
December 31, 2019 | 1.143M |
September 30, 2019 | 1.59M |
June 30, 2019 | 2.604M |
March 31, 2019 | 1.32M |
December 31, 2018 | 1.771M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.143M
Minimum
Dec 2019
8.941M
Maximum
Mar 2023
3.605M
Average
3.248M
Median
Accounts Payable (Quarterly) Benchmarks
Emergent BioSolutions Inc | 100.20M |
Avinger Inc | 0.777M |
Tonix Pharmaceuticals Holding Corp | 6.649M |
Skye Bioscience Inc | 1.095M |
Axsome Therapeutics Inc | 53.79M |